Sumitomo Pharma America, Inc.
Clinical trials sponsored by Sumitomo Pharma America, Inc., explained in plain language.
-
New pill tested for Tough-to-Treat returning brain cancer
Disease control OngoingThis is an early-stage study to test the safety and find the right dose of an experimental oral drug called DSP-0390. It is for adults whose aggressive brain tumors (high-grade gliomas) have come back after previous treatment. The main goals are to see how safe the drug is and ho…
Phase: EARLY_PHASE1 • Sponsor: Sumitomo Pharma America, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Scientists seek better ways to measure fading vision in rare eye disease
Knowledge-focused OngoingThis study aims to understand how vision declines in people with severe retinitis pigmentosa, a rare genetic eye disease. Researchers will follow 12 adults for one year to identify which vision tests work best for tracking disease progression. The study doesn't test treatments bu…
Sponsor: Sumitomo Pharma America, Inc. • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC